ASNS: Actelis Networks, Inc. Stock

by  •  • Comments Off on ASNS: Actelis Networks, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 7.16
Enterprise Value ($M) 6.10
Book Value ($M) 2.83
Book Value / Share 0.47
Price / Book 2.53
NCAV ($M) 1.30
NCAV / Share 0.22
Price / NCAV 5.49

Profitability (mra)
Return on Invested Capital (ROIC) -1.00
Return on Assets (ROA) -0.40
Return on Equity (ROE) -5.38

Liquidity (mrq)
Quick Ratio 0.96
Current Ratio 1.42

Balance Sheet (mrq) ($M)
Current Assets 7.22
Assets 8.75
Liabilities 5.92
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
9 days ago 13G/A Armistice Capital, Llc 4.99 4.84

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 15,255 58,644 26.01
2024-11-21 3,814 49,770 7.66
2024-11-20 23,839 85,065 28.02
2024-11-19 17,897 94,658 18.91
2024-11-18 82,525 269,297 30.64

(click for more detail)

Similar Companies
APTO – Aptose Biosciences Inc. APVO – Aptevo Therapeutics Inc.
ARTL – Artelo Biosciences, Inc. ASRT – Assertio Holdings, Inc.
ATNF – 180 Life Sciences Corp.


Financial data and stock pages provided by
Fintel.io